• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

世界卫生组织头颈部肿瘤分类第4版更新:涎腺肿瘤

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland.

作者信息

Seethala Raja R, Stenman Göran

机构信息

Department of Pathology and Laboratory Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

Department of Pathology and Genetics, Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden.

出版信息

Head Neck Pathol. 2017 Mar;11(1):55-67. doi: 10.1007/s12105-017-0795-0. Epub 2017 Feb 28.

DOI:10.1007/s12105-017-0795-0
PMID:28247227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5340736/
Abstract

The salivary gland section in the 4th edition of the World Health Organization classification of head and neck tumors features the description and inclusion of several entities, the most significant of which is represented by (mammary analogue) secretory carcinoma. This entity was extracted mainly from acinic cell carcinoma based on recapitulation of breast secretory carcinoma and a shared ETV6-NTRK3 gene fusion. Also new is the subsection of "Other epithelial lesions," for which key entities include sclerosing polycystic adenosis and intercalated duct hyperplasia. Many entities have been compressed into their broader categories given clinical and morphologic similarities, or transitioned to a different grouping as was the case with low-grade cribriform cystadenocarcinoma reclassified as intraductal carcinoma (with the applied qualifier of low-grade). Specific grade has been removed from the names of the salivary gland entities such as polymorphous adenocarcinoma, providing pathologists flexibility in assigning grade and allowing for recognition of a broader spectrum within an entity. Cribriform adenocarcinoma of (minor) salivary gland origin continues to be divisive in terms of whether it should be recognized as a distinct category. This chapter also features new key concepts such as high-grade transformation. The new paradigm of translocations and gene fusions being common in salivary gland tumors is featured heavily in this chapter.

摘要

《世界卫生组织头颈部肿瘤分类》第4版中的唾液腺部分对多个实体进行了描述并将其纳入其中,其中最重要的是(乳腺样)分泌性癌。该实体主要是基于乳腺分泌性癌的重现以及共享的ETV6-NTRK3基因融合而从腺泡细胞癌中分离出来的。“其他上皮性病变”小节也是新增内容,其关键实体包括硬化性多囊性腺病和闰管增生。鉴于临床和形态学上的相似性,许多实体已被归入更广泛的类别,或者像低度筛状囊腺癌重新分类为导管内癌(加上低度的限定词)那样,转变为不同的分组。唾液腺实体如多形性腺瘤的名称中已去掉了特定分级,这为病理学家在分级时提供了灵活性,并允许在一个实体内识别更广泛的谱系。(小)唾液腺来源的筛状腺癌在是否应被视为一个独特类别方面仍存在分歧。本章还介绍了高级别转化等新的关键概念。唾液腺肿瘤中常见的易位和基因融合这一新模式在本章中得到了重点阐述。

相似文献

1
Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland.世界卫生组织头颈部肿瘤分类第4版更新:涎腺肿瘤
Head Neck Pathol. 2017 Mar;11(1):55-67. doi: 10.1007/s12105-017-0795-0. Epub 2017 Feb 28.
2
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands.世界卫生组织头颈部肿瘤分类第 5 版更新:唾液腺。
Head Neck Pathol. 2022 Mar;16(1):40-53. doi: 10.1007/s12105-022-01420-1. Epub 2022 Mar 21.
3
Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.唾液腺癌管内癌的分子特征分析揭示了一组存在 NCOA4-RET 和新型 TRIM27-RET 融合的肿瘤:17 例报告。
Am J Surg Pathol. 2018 Nov;42(11):1445-1455. doi: 10.1097/PAS.0000000000001133.
4
Newly Described Entities in Salivary Gland Pathology.唾液腺病理学中的新描述实体
Am J Surg Pathol. 2017 Aug;41(8):e33-e47. doi: 10.1097/PAS.0000000000000883.
5
[Salivary gland tumors: 2022 WHO blue book and beyond].[唾液腺肿瘤:2022年世界卫生组织蓝皮书及其他]
Ann Pathol. 2024 May;44(3):175-182. doi: 10.1016/j.annpat.2024.02.005. Epub 2024 Mar 5.
6
Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.乳腺型分泌性涎腺癌,含有 ETV6-NTRK3 融合基因:一种迄今尚未描述的涎腺肿瘤实体。
Am J Surg Pathol. 2010 May;34(5):599-608. doi: 10.1097/PAS.0b013e3181d9efcc.
7
The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.分子检测在唾液腺癌鉴别诊断中的作用。
Am J Surg Pathol. 2018 Feb;42(2):e11-e27. doi: 10.1097/PAS.0000000000000980.
8
Salivary Gland Tumors: Current Concepts and Controversies.唾液腺肿瘤:当前概念与争议
Surg Pathol Clin. 2017 Mar;10(1):155-176. doi: 10.1016/j.path.2016.11.004.
9
Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.涎腺乳腺样分泌癌:一种与ETV6基因重排相关的新实体。
Virchows Arch. 2015 Mar;466(3):245-54. doi: 10.1007/s00428-014-1701-8. Epub 2014 Dec 12.
10
Salivary Gland Neoplasms: Does Morphological Diversity Reflect Tumor Heterogeneity.涎腺肿瘤:形态多样性是否反映肿瘤异质性。
Pathobiology. 2018;85(1-2):85-95. doi: 10.1159/000479070. Epub 2017 Sep 21.

引用本文的文献

1
Evaluation of Inflammatory Biomarkers in Parotid Tumors.腮腺肿瘤中炎症生物标志物的评估
Med Sci Monit. 2025 Aug 17;31:e947334. doi: 10.12659/MSM.947334.
2
Polymorphous adenocarcinoma: a review of the literature and presentation of a case in an uncommon anatomical area.多形性腺癌:文献综述及罕见解剖部位病例报告
Med Pharm Rep. 2025 Jul;98(3):403-408. doi: 10.15386/mpr-2882. Epub 2025 Jul 30.
3
Rare Tumors of Oral Cavity: A Case Report and Literature Review on Secretory Carcinoma of Minor Salivary Glands.口腔罕见肿瘤:一例小涎腺分泌性癌病例报告及文献综述
Clin Exp Dent Res. 2025 Aug;11(4):e70200. doi: 10.1002/cre2.70200.
4
Prognostic relevance of prospero homeobox 1 and metastasis tumor antigen 1 in patients with malignant salivary gland tumors: a clinicopathological study.prospero同源盒蛋白1和转移肿瘤抗原1在恶性涎腺肿瘤患者中的预后相关性:一项临床病理研究
Eur J Med Res. 2025 Jul 14;30(1):622. doi: 10.1186/s40001-025-02863-2.
5
Carcinoma ex Pleomorphic Adenoma: Multi-Institutional Retrospective Cohort Study.多形性腺瘤恶变:多机构回顾性队列研究
OTO Open. 2025 Jul 11;9(3):e70147. doi: 10.1002/oto2.70147. eCollection 2025 Jul-Sep.
6
Surgery Alone without Adjuvant Radiation Therapy for High- or Intermediate-Grade Salivary Gland Cancer.高分级或中分级唾液腺癌单纯手术治疗而非辅助性放射治疗
ORL J Otorhinolaryngol Relat Spec. 2025 Jun 28:1-10. doi: 10.1159/000547198.
7
Classification of Parotid Tumors with Robust Radiomic Features from DCE- and DW-MRI.利用动态对比增强磁共振成像(DCE-MRI)和扩散加权磁共振成像(DW-MRI)的稳健影像组学特征对腮腺肿瘤进行分类
J Imaging. 2025 Apr 17;11(4):122. doi: 10.3390/jimaging11040122.
8
Oncocytic Tumors in the Salivary Gland: Cytopathological, Pathological, and Molecular Features.涎腺嗜酸性细胞瘤:细胞病理学、病理学及分子特征
Acta Cytol. 2025 Apr 1:1-12. doi: 10.1159/000544802.
9
Gold-Nanoparticles Reflectance Discriminates Benign from Malignant Salivary Gland Neoplasms.金纳米颗粒反射率可区分涎腺良性肿瘤与恶性肿瘤。
J Clin Med. 2025 Mar 1;14(5):1672. doi: 10.3390/jcm14051672.
10
The Transcriptomic and Gene Fusion Landscape of Pleomorphic Salivary Gland Adenomas.多形性腺瘤的转录组学与基因融合图谱
Genes Chromosomes Cancer. 2025 Jan;64(1):e70023. doi: 10.1002/gcc.70023.

本文引用的文献

1
Distinctive Patterns of CTNNB1 (β-Catenin) Alterations in Salivary Gland Basal Cell Adenoma and Basal Cell Adenocarcinoma.涎腺基底细胞腺瘤和基底细胞腺癌中CTNNB1(β-连环蛋白)改变的独特模式
Am J Surg Pathol. 2016 Aug;40(8):1143-50. doi: 10.1097/PAS.0000000000000669.
2
The landscape of gene fusions and somatic mutations in salivary gland neoplasms - Implications for diagnosis and therapy.唾液腺肿瘤中基因融合与体细胞突变的格局——对诊断和治疗的启示
Oral Oncol. 2016 Jun;57:63-9. doi: 10.1016/j.oraloncology.2016.04.002. Epub 2016 Apr 18.
3
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).乳腺类似物分泌癌(MASC)中ETV6-NTRK3基因被鉴定后,MASC背后隐藏着什么:恩曲替尼的临床反应和获得性耐药。
Ann Oncol. 2016 May;27(5):920-6. doi: 10.1093/annonc/mdw042. Epub 2016 Feb 15.
4
Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.涎腺乳腺样分泌性癌:25例ETV6基因重排肿瘤的分子分析,标准逆转录聚合酶链反应未检测到经典ETV6-NTRK3融合转录本:4例携带ETV6-X基因融合病例报告
Am J Surg Pathol. 2016 Jan;40(1):3-13. doi: 10.1097/PAS.0000000000000537.
5
Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression.涎腺导管癌:大汗腺形态的优势、组织学变异的发生率及雄激素受体表达
Am J Surg Pathol. 2015 May;39(5):705-13. doi: 10.1097/PAS.0000000000000413.
6
Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.一致的PLAG1和HMGA2异常可将多形性腺瘤癌变与其原发性对应物区分开来。
Hum Pathol. 2015 Jan;46(1):26-33. doi: 10.1016/j.humpath.2014.08.017. Epub 2014 Sep 7.
7
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands.唾液腺多形性低度腺癌中激活PRKD1的热点体细胞突变。
Nat Genet. 2014 Nov;46(11):1166-9. doi: 10.1038/ng.3096. Epub 2014 Sep 21.
8
Prognostic features in mucoepidermoid carcinoma of major salivary glands with emphasis on tumour histologic grading.大涎腺黏液表皮样癌的预后特征,重点在于肿瘤组织学分级。
Histopathology. 2014 Dec;65(6):793-804. doi: 10.1111/his.12488. Epub 2014 Aug 26.
9
Polymorphous low grade adenocarcinoma has a consistent p63+/p40- immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma.多形性低度恶性腺癌具有一致的p63+/p40-免疫表型,这有助于将其与腺样囊性癌和细胞型多形性腺瘤区分开来。
Head Neck Pathol. 2015 Mar;9(1):79-84. doi: 10.1007/s12105-014-0554-4. Epub 2014 Jun 27.
10
Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin.唾液腺来源筛状腺癌中的新型PRKD基因重排和变异融合
Genes Chromosomes Cancer. 2014 Oct;53(10):845-56. doi: 10.1002/gcc.22195. Epub 2014 Jun 18.